Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
To conduct an open-label randomized controlled trial on a short course of interferon β-1b and
clofazimine combination treatment for patients hospitalized for COVID-19 infection. To assess
its safety and clinical efficacy.